2018 News Releases

Webcast ImageWebcast - Replay
Q1 2018 AtriCure, Inc. Earnings Conference Call
04/26/18 at 4:30 p.m. ET
Q1 2018 AtriCure, Inc. Earnings Conference Call
Thursday, April 26, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
AtriCure, Inc. at Needham & Company’s 17th Annual Healthcare Conference
03/27/18 at 1:30 p.m. ET
AtriCure, Inc. at Needham & Company’s 17th Annual Healthcare Conference
Tuesday, March 27, 2018 1:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Q4 and Full Year 2017 AtriCure, Inc. Earnings Conference Call
02/26/18 at 4:30 p.m. ET
Q4 and Full Year 2017 AtriCure, Inc. Earnings Conference Call
Monday, February 26, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
04/26/18AtriCure Reports First Quarter 2018 Financial Results
Worldwide revenue of $47.0 million – an increase of 13.9% year over year U.S. revenue of $38.4 million – an increase of 15.5% year over year International revenue of $8.6 million – an increase of 6.9% year over year MASON, Ohio--(BUSINESS WIRE)--Apr. 26, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (... 
Printer Friendly Version
04/05/18AtriCure to Announce First Quarter 2018 Financial Results
MASON, Ohio--(BUSINESS WIRE)--Apr. 5, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its first quarter 2018 financial results on Thursday, April 26, 2018. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Thursday, April 26, 2018 to discuss its first quarter 2018 financial re... 
Printer Friendly Version
03/15/18AtriCure to Present at the Needham & Company’s 17th Annual Healthcare Conference
MASON, Ohio--(BUSINESS WIRE)--Mar. 15, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the Needham & Company’s 17th Annual Healthcare Conference at the Westin Grand Central in New York on Tuesday, March 27, 2018. Management is scheduled to present at 1:30 p.m. Eastern Time. A live audio webcast ... 
Printer Friendly Version
02/26/18AtriCure Reports Fourth Quarter and Full Year 2017 Financial Results
2017 worldwide revenue of $174.7 million – an increase of 12.6% year over year 2017 U.S. revenue of $138.4 million – an increase of 13.1% year over year 2017 international revenue of $36.3 million – an increase of 11.0% year over year MASON, Ohio--(BUSINESS WIRE)--Feb. 26, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib)... 
Printer Friendly Version
02/22/18AtriCure Launches the AtriClip® FLEX•V™ Device in the United States
New device builds on the “V” clip technology, offering increased flexibility in left atrial appendage management MASON, Ohio--(BUSINESS WIRE)--Feb. 22, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced that it has launched the AtriClip FLEX•V™ Left Atrial Appendage (LAA) Exclusion System in the United States. The new AtriCli... 
Printer Friendly Version
02/20/18AtriCure Names Scott Drake Board Chairman
Richard Johnston and Elizabeth D. Krell, Ph.D. are Retiring from the Board of Directors in May MASON, Ohio--(BUSINESS WIRE)--Feb. 20, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that Scott Drake has been named Board Chairman, effective at the annual meeting in May of this year. Concurrent with this appointment... 
Printer Friendly Version
02/07/18AtriCure to Announce Fourth Quarter and Full Year 2017 Financial Results
MASON, Ohio--(BUSINESS WIRE)--Feb. 7, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its fourth quarter and full year 2017 financial results on Monday, February 26, 2018. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Monday, February 26, 2018 to discuss its fourth quarter and fu... 
Printer Friendly Version
01/08/18AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
MASON, Ohio--(BUSINESS WIRE)--Jan. 8, 2018-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced preliminary financial results for the fourth quarter and full year 2017 and provided 2018 financial guidance. Preliminary and unaudited revenue for fourth quarter 2017 is expected to be approximately $46.1 million, reflecting growth of... 
Printer Friendly Version